By proceeding, you agree to our Terms of Use and Privacy Policy.
With 2023 on track to see further growth in the immuno-oncology field, the availability of tools that offers drug developers & researchers advantages that weren’t available to them even a few years ago is increasing rapidly.
Network with experts, including Amgen, and Umoja Therapeutics to increase your clinical relevancy.
Discover how to improve in vivo preclinical toolbox to usher in the next generation of transgenic mouse models to advance therapies to the clinic faster.
Find solutions to combination therapy challenges including dosing, tumor heterogeneity, target engagement, & resistance through sessions.
Meet and network with selected CROs, model developers and academics to hear their latest platforms and form meaningful partnerships.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities.
Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research.
Cancer. Diabetes. Alzheimer’s. Heart Disease. Parkinson’s. The Jackson Laboratory (JAX) leads the search to cure diseases rooted in our DNA.
Scientist.com is the world’s largest marketplace for medical research. We help pharmaceutical scientists discover life-saving medicines in less time and at lower cost. Our mission is to make it possible to cure all human disease by 2050.
Crown Bioscience, Inc. is a platform technology company providing drug discovery and development services in the areas of Oncology and Inflammation.
Certis began its journey in precision medicine, helping individual cancer patients and their oncologists determine--with certainty--the best available treatments for their unique cancers.
Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins.
We have six company Core Values – Trust, Loyalty, Respect for Others, Honesty, Integrity, and Commitment – that capture our philosophy towards our people and customers.
Champions Oncology, Inc. provides an end-to-end range of research and development solutions and services that improve the productivity of oncology drug development.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.